BioNTech, Pfizer to develop single-dose vaccine for COVID, influenza

Novembre 3, 2022

Pfizer and BioNTech began a study of a single-dose vaccine candidate for influenza and COVID-19, BioNTech said Thursday.

The study will combine Pfizer’s quadrivalent modRNA-based influenza vaccin…